HIGHLIGHTS OF PRESCRIBING INFORMATION These
... has not been studied in patients with acutely deteriorating asthma. The initiation of DULERA in this setting is not appropriate. Increasing use of inhaled, short-acting beta2-agonists is a marker of deteriorating asthma. In this situation, the patient requires immediate re-evaluation with reassessme ...
... has not been studied in patients with acutely deteriorating asthma. The initiation of DULERA in this setting is not appropriate. Increasing use of inhaled, short-acting beta2-agonists is a marker of deteriorating asthma. In this situation, the patient requires immediate re-evaluation with reassessme ...
¡Salud! - A Publication of the Arizona Chapter of the American
... BAD BLOOD – A CURIOUS CASE OF RECURRENT HEMOPTYSIS ...
... BAD BLOOD – A CURIOUS CASE OF RECURRENT HEMOPTYSIS ...
Management of Postoperative Spondylodiscitis with and without
... 14). Additionally, anterior debridement combined with onestage/staged posterior internal fixation has been used to treat patients with primary pyogenic vertebral osteomyelitis (10, 15, 36, 40, 43). There are few studies on anterior debridement for the treatment of postoperative spondylodiscitis, how ...
... 14). Additionally, anterior debridement combined with onestage/staged posterior internal fixation has been used to treat patients with primary pyogenic vertebral osteomyelitis (10, 15, 36, 40, 43). There are few studies on anterior debridement for the treatment of postoperative spondylodiscitis, how ...
Isthmic spondylolisthesis
... Nonoperative. Most patients who present with spondylolisthesis are asymptomatic; however, in the pediatric and adolescent population, spondylolisthesis is the predominant cause of low-back pain and sciatica. Nevertheless, nonoperative treatment is successful in the majority of cases, with surgical i ...
... Nonoperative. Most patients who present with spondylolisthesis are asymptomatic; however, in the pediatric and adolescent population, spondylolisthesis is the predominant cause of low-back pain and sciatica. Nevertheless, nonoperative treatment is successful in the majority of cases, with surgical i ...
GHB Withdrawal Syndrome
... slightly less severe. Brief episodes of significant tachycardia begin (heart rate 160 or more) early in GHB withdrawal. Treatment Guidelines for GHB Withdrawal The following information is based on a review of the limited medical literature and clinical experience, and is not intended for the use of ...
... slightly less severe. Brief episodes of significant tachycardia begin (heart rate 160 or more) early in GHB withdrawal. Treatment Guidelines for GHB Withdrawal The following information is based on a review of the limited medical literature and clinical experience, and is not intended for the use of ...
when to start hiv treatment: evidence from a quasi
... diagnostics such as CD4 counts and blood lipid levels are analyzed by laboratory technician (often offsite) and are less vulnerable to manipulation and/or heaping (Almond et al. 2010; Barreca et al. 2011; Shigeoka & Fushimi 2014). Finally, the exclusion restriction is often plausible: tests occur im ...
... diagnostics such as CD4 counts and blood lipid levels are analyzed by laboratory technician (often offsite) and are less vulnerable to manipulation and/or heaping (Almond et al. 2010; Barreca et al. 2011; Shigeoka & Fushimi 2014). Finally, the exclusion restriction is often plausible: tests occur im ...
Spasticity in adults: management using botulinum toxin National guidelines
... BT is licensed in the UK for treatment of focal spasticity in the upper limb. It has also become an accepted part of routine management in other muscle groups. G BT should only be injected by clinicians experienced in the assessment and management of spasticity. The mainstay of spasticity management ...
... BT is licensed in the UK for treatment of focal spasticity in the upper limb. It has also become an accepted part of routine management in other muscle groups. G BT should only be injected by clinicians experienced in the assessment and management of spasticity. The mainstay of spasticity management ...
Botulinum Toxin cover - British Society of Rehabilitation Medicine
... BT is licensed in the UK for treatment of focal spasticity in the upper limb. It has also become an accepted part of routine management in other muscle groups. G BT should only be injected by clinicians experienced in the assessment and management of spasticity. The mainstay of spasticity management ...
... BT is licensed in the UK for treatment of focal spasticity in the upper limb. It has also become an accepted part of routine management in other muscle groups. G BT should only be injected by clinicians experienced in the assessment and management of spasticity. The mainstay of spasticity management ...
Bulletin #97
... (b) For treatment of paediatric patients with active juvenile rheumatoid arthritis who have failed one DMARD. gatifloxacin, tablet, 400mg (Tequin-BMY) Exception Drug Status criteria has been revised as follows: (b) Infections known to be resistant to alternative antibiotics. Resistance must be deter ...
... (b) For treatment of paediatric patients with active juvenile rheumatoid arthritis who have failed one DMARD. gatifloxacin, tablet, 400mg (Tequin-BMY) Exception Drug Status criteria has been revised as follows: (b) Infections known to be resistant to alternative antibiotics. Resistance must be deter ...
the full sized image
... organism, as well as delivery matrix of the probiotic. Furthermore the tissue compartment and assay method by which inflammatory mediators are quantified in clinical trials is a debated issue. The goal of the current study was to evaluate the effect of one probiotic species, Bifidobacterium animalis ...
... organism, as well as delivery matrix of the probiotic. Furthermore the tissue compartment and assay method by which inflammatory mediators are quantified in clinical trials is a debated issue. The goal of the current study was to evaluate the effect of one probiotic species, Bifidobacterium animalis ...
Contemporary management of acute ST elevation myocardial infarction Arntz
... potential was only investigated in a number of small and one larger study. The big EMIP-study (13) was also prematurely stopped due to lack of sponsorship. However, in general these studies proved the principal rationales of pre-hospital lysis were safe and showed a trend towards its use. Even so, t ...
... potential was only investigated in a number of small and one larger study. The big EMIP-study (13) was also prematurely stopped due to lack of sponsorship. However, in general these studies proved the principal rationales of pre-hospital lysis were safe and showed a trend towards its use. Even so, t ...
Uitnodigi - Publication Online
... (VEGF-A) (25). In contrast, Hasan et al. concluded in an in vitro study with five different corticosteroids that these drugs stimulate apoptosis via the increase of cytochrome B and stimulate the release of anti-angiogenic factors via an increase in mast cells (26). Currently it is known that cortic ...
... (VEGF-A) (25). In contrast, Hasan et al. concluded in an in vitro study with five different corticosteroids that these drugs stimulate apoptosis via the increase of cytochrome B and stimulate the release of anti-angiogenic factors via an increase in mast cells (26). Currently it is known that cortic ...
The use of low-dose naltrexone (LDN) as a novel anti
... LDN has been tested experimentally in a small number of chronic pain conditions. One such condition is fibromyalgia (FM). FM is a chronic pain disorder that is characterized by diffuse musculoskeletal pain and sensitivity to mechanical stimulation as well as profound fatigue, cognitive disruption, a ...
... LDN has been tested experimentally in a small number of chronic pain conditions. One such condition is fibromyalgia (FM). FM is a chronic pain disorder that is characterized by diffuse musculoskeletal pain and sensitivity to mechanical stimulation as well as profound fatigue, cognitive disruption, a ...
Acne Vulgaris - Patient.co.uk
... Any systemic treatment often takes several months to show any improvement and should therefore be continued for 3-4 months, if tolerated, before effectiveness can be properly assessed. Systemic treatment may be combined with topical treatment. People with dark skin often need early systemic treatmen ...
... Any systemic treatment often takes several months to show any improvement and should therefore be continued for 3-4 months, if tolerated, before effectiveness can be properly assessed. Systemic treatment may be combined with topical treatment. People with dark skin often need early systemic treatmen ...
Canadian Stroke Best Practice Recommendations
... ischemic attack (TIA) (1). Stroke is also the third cause of death in Canada and a leading cause of disability (2). The Canadian Stroke Best Practice Recommendations (CSBPR) are evidence-based guidelines that are updated and released every two-years (or more frequently as necessary) (2). They addres ...
... ischemic attack (TIA) (1). Stroke is also the third cause of death in Canada and a leading cause of disability (2). The Canadian Stroke Best Practice Recommendations (CSBPR) are evidence-based guidelines that are updated and released every two-years (or more frequently as necessary) (2). They addres ...
The role of endoscopy in the management of patients with known
... The role of endoscopy in the management of patients with known and suspected colonic obstruction and pseudo-obstruction This is one of a series of statements discussing the use of gastrointestinal endoscopy in common clinical situations. The Standards of Practice Committee of the American Society fo ...
... The role of endoscopy in the management of patients with known and suspected colonic obstruction and pseudo-obstruction This is one of a series of statements discussing the use of gastrointestinal endoscopy in common clinical situations. The Standards of Practice Committee of the American Society fo ...
Electroconvulsive Therapy Today
... hallucinations that put him at risk for hurting himself or others, there is not time to wait for antidepressants to take effect. In these emergency situations, ECT can offer faster benefits than medications. 2. Have several antidepressants been ineffective? When a person has failed two or three adeq ...
... hallucinations that put him at risk for hurting himself or others, there is not time to wait for antidepressants to take effect. In these emergency situations, ECT can offer faster benefits than medications. 2. Have several antidepressants been ineffective? When a person has failed two or three adeq ...
Bibliography for HGH - Hormone Restoration
... Patients with childhood-onset growth hormone (GH) deficiency (GHD) show impairments in mood and cognitive functioning which may resolve following GH substitution. Brain functional magnetic resonance imaging (fMRI) during performance of a memory task was used to assess the cerebral activity of such p ...
... Patients with childhood-onset growth hormone (GH) deficiency (GHD) show impairments in mood and cognitive functioning which may resolve following GH substitution. Brain functional magnetic resonance imaging (fMRI) during performance of a memory task was used to assess the cerebral activity of such p ...
... three quarters of all cases seen in movement disorders centers.3 Action tremor is present during the voluntary contraction of muscles, and can be subdivided into four types: postural, kinetic, isometric, and task-specific. Postural tremor is seen during the maintenance of an anti-gravity posture, su ...
Osteopathic Physicians` Guide - American Osteopathic Association
... States.2 Clinicians cannot cure this disease but can alleviate the debilitating effects of this disease with early diagnosis and stepwise intervention. A majority of COPD cases can be attributed to firsthand or secondhand tobacco smoke exposure. Remaining cases can be a result of genetic susceptibil ...
... States.2 Clinicians cannot cure this disease but can alleviate the debilitating effects of this disease with early diagnosis and stepwise intervention. A majority of COPD cases can be attributed to firsthand or secondhand tobacco smoke exposure. Remaining cases can be a result of genetic susceptibil ...
Medicine`s inconvenient truth: The placebo/nocebo effect
... In contrast, a nocebo (from the Latin, ‘I shall cause harm’) is an agent whose administration results in a noxious or detrimental effect on health that cannot be attributed to the properties of the substance or intervention itself. Nocebo effects therefore are noxious effects arising from the admini ...
... In contrast, a nocebo (from the Latin, ‘I shall cause harm’) is an agent whose administration results in a noxious or detrimental effect on health that cannot be attributed to the properties of the substance or intervention itself. Nocebo effects therefore are noxious effects arising from the admini ...
Electroconvulsive Therapy - Canadian Psychiatric Association
... also be necessary to reduce treatment frequency if excessive cognitive side effects occur. Practices such as prolonged daily administrations of ECT or multiple seizure inductions per treatment session are not supported by scientific evidence, and are not recommended.9 However, brief periods of daily ...
... also be necessary to reduce treatment frequency if excessive cognitive side effects occur. Practices such as prolonged daily administrations of ECT or multiple seizure inductions per treatment session are not supported by scientific evidence, and are not recommended.9 However, brief periods of daily ...
$doc.title
... Boudewyns & Hyer, 1996; Devilly et al., 1998; Gosselin & Matthews, 1995; Pitman et al., 1996; Renfrey & Spates, 1994; Wilson et al., 1996). In all but one of the aforemen tioned dismantling studies, the effects of EMDR did not differ from the effects of EMDR minus eye movements; unfortunately, the ...
... Boudewyns & Hyer, 1996; Devilly et al., 1998; Gosselin & Matthews, 1995; Pitman et al., 1996; Renfrey & Spates, 1994; Wilson et al., 1996). In all but one of the aforemen tioned dismantling studies, the effects of EMDR did not differ from the effects of EMDR minus eye movements; unfortunately, the ...
Lanoxin® PDF - Covis Pharma
... cardiac arrhythmias [first-degree, second-degree (Wenckebach), or third-degree heart block (including asystole); atrial tachycardia with block; AV dissociation; accelerated junctional (nodal) rhythm; unifocal or multiform ventricular premature contractions (especially bigeminy or trigeminy); ventric ...
... cardiac arrhythmias [first-degree, second-degree (Wenckebach), or third-degree heart block (including asystole); atrial tachycardia with block; AV dissociation; accelerated junctional (nodal) rhythm; unifocal or multiform ventricular premature contractions (especially bigeminy or trigeminy); ventric ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.